Literature DB >> 19556249

'Marginal medicine': targeting comparative effectiveness research to reduce waste.

Ari Hoffman1, Steven D Pearson.   

Abstract

Many policymakers believe that comparative effectiveness research will reduce "waste" in the U.S. health care system by providing guidance on what health care options work best for different patients. How such research will produce findings that identify waste has not been clearly elucidated. This paper presents a conceptual framework for different evidentiary categories of what we call "marginal medicine." This framework could help clinicians, researchers, and policymakers align the results of comparative effectiveness research with efforts to identify opportunities to improve the value of health care services.

Entities:  

Mesh:

Year:  2009        PMID: 19556249     DOI: 10.1377/hlthaff.28.4.w710

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  12 in total

Review 1.  State-of-the-art and future directions in multilevel interventions across the cancer control continuum.

Authors:  Kurt C Stange; Erica S Breslau; Allen J Dietrich; Russell E Glasgow
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

2.  A science of connectedness.

Authors:  Kurt C Stange
Journal:  Ann Fam Med       Date:  2009 Sep-Oct       Impact factor: 5.166

3.  Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question.

Authors:  Jinoos Yazdany; Gabriela Schmajuk; Mark Robbins; David Daikh; Ashley Beall; Edward Yelin; Jennifer Barton; Adam Carlson; Mary Margaretten; Joann Zell; Lianne S Gensler; Victoria Kelly; Kenneth Saag; Charles King
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

4.  Multilevel factors affecting quality: examples from the cancer care continuum.

Authors:  Jane Zapka; Stephen H Taplin; Patricia Ganz; Eva Grunfeld; Katherine Sterba
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

5.  Refocusing knowledge generation, application, and education: raising our gaze to promote health across boundaries.

Authors:  Kurt C Stange
Journal:  Am J Prev Med       Date:  2011-10       Impact factor: 5.043

6.  Value-based insurance design: more health at any price.

Authors:  A Mark Fendrick; Jenifer J Martin; Alison E Weiss
Journal:  Health Serv Res       Date:  2011-12-08       Impact factor: 3.402

7.  A framework for understanding cancer comparative effectiveness research data needs.

Authors:  William R Carpenter; Anne-Marie Meyer; Amy P Abernethy; Til Stürmer; Michael R Kosorok
Journal:  J Clin Epidemiol       Date:  2012-11       Impact factor: 6.437

Review 8.  Data for cancer comparative effectiveness research: past, present, and future potential.

Authors:  Anne-Marie Meyer; William R Carpenter; Amy P Abernethy; Til Stürmer; Michael R Kosorok
Journal:  Cancer       Date:  2012-04-19       Impact factor: 6.860

9.  Funding of US biomedical research, 2003-2008.

Authors:  E Ray Dorsey; Jason de Roulet; Joel P Thompson; Jason I Reminick; Ashley Thai; Zachary White-Stellato; Christopher A Beck; Benjamin P George; Hamilton Moses
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

10.  Trial design for ineffectiveness research: a mixed-methods survey.

Authors:  Kevin Riggs; Joshua Richman; Stefan Kertesz
Journal:  BMJ Evid Based Med       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.